Skip to main content

Table 2 Characteristics and pharmacokinetic parameters of dexmedetomidine infusions in 13 intensive care patients

From: Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients

 

Patient number

  

Variable

1

2

3

4

5

6

7

8

9

10

11

12

13

Mean

CV (%)

Rate of the 12-h initial infusion (μg/kg/h)

0.1

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.6a

58.1

Maximum infusion rate (μg/kg/h)

0.1

2.1

2.5

2.5

2.5

2.5

2.5

0.95

0.7

2.5

1.2

2.5

2.5

1.5a

117

Length of infusion (h)

40

142

137

88

55

304

137

30

121

330

13

72

192

92.0a

117

Cumulative dose (mg)

0.34

11

25

8.7

8.0

56

17

1.4

2.4

82

1.1

13

46

21.0

120

AUC0-∞ (ng h/ml)

17.8

376

550

174

252

924

337

39.0

100

1,530

29.7

350

583

213a

233

Extrapolated fraction of AUC0-∞ (%)

1.3

0.1

0.0

0.1

22.0

0.0

0.0

0.6

0.2

0.0

37.1

9.3

0.0

  

t1/2 (h)

4.5

4.2

2.9

5.0

-

2.4

3.4

3.3

6.9

5.1

-

-

2.1

3.7a

38.1

Cl (L/h)

18.9

30.4

45.4

50.4

31.8

60.7

51.5

35.5

23.7

53.7

36.1

36.7

79.0

39.7a

40.9

V (L)

123

184

193

362

-

213

252

170

234

391

-

-

234

223a

35.3

  1. Because of missing samples for subjects 5, 11, and 12, it was not possible to define the elimination-phase parameters for these subjects, and the area under the dexmedetomidine concentration-time curve extrapolated to infinity (AUC0-∞) was estimated by using the mean elimination half-life of the other patients. Subject 5 received hemodiafiltration. Cl, plasma clearance; CV, coefficient of variation; t1/2, elimination half-life; V, volume of distribution during elimination; ageometric mean (backtransformed mean of the values on the logarithmic scale).